tirzepatide a vs. Semaglutide: Which Weight Loss Medication Is Right for You? Peptide of the Week: Tirzepatide,
Description
Gursoy A, Erdogan MF, Cin MO, Cesur M, Baskal N
The clinical adoption of GLP-1 receptor agonists has outpaced manufacturing, leading to significant supply chain challenges that impact accessibility (Garvey, Diabetes, Obesity and Metabolism )
Yes, abdominal pain is a recognised and common side effect of Ozempic (semaglutide), a GLP-1 receptor agonist used to treat type 2 diabetes in the UK
He has a genuine interest in the well being of his patients
The mechanism is generally telogen effluvium driven by rapid weight loss rather than a direct effect of tirzepatide, similar to what is seen after bariatric surgery or any aggressive caloric deficit
